As of Jan 24th, we're $5,100 in the red for the year. Please donate here to support this vital work.
Subscribe here to our free email list

Pharmaceutical Corruption Media Articles
Excerpts of Key Pharmaceutical Corruption Media Articles in Major Media


Below are key excerpts of highly revealing pharmaceutical corruption articles reported in the major media. Links are provided to the full articles on major media websites. If any link fails to function, read this webpage. These pharmaceutical corruption articles are listed by article date. You can also explore the articles listed by order of importance or by date posted. By choosing to educate ourselves on these important issues and to spread the word, we can and will build a brighter future.


Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.


After Year of Vaccine Profiteering, Pfizer Hikes Prices on 125 Drugs
2022-01-13, Common Dreams
https://www.commondreams.org/news/2022/01/13/after-year-vaccine-profiteering-...

After raking in enormous profits from its coronavirus vaccine in 2021, the U.S.-based pharmaceutical giant Pfizer has kicked off the new year by hiking the prices of more than 120 of its drugs, resulting in significantly higher costs for patients amid a deadly pandemic. That's according to a new report released Thursday by Patients for Affordable Drugs (P4AD), which found that pharmaceutical companies have raised the prices of 554 medicines this month alone. Pfizer led the way with 125 price hikes to start 2022, leading P4AD to label the company the industry's "poster child for greed." "Due to sales of its Covid-19 vaccine, which is set to be the best-selling drug of all time, Pfizer shattered profit records in 2021. Projected sales for 2022 are $54.5 billion–more than double the previous record for one-year sales for a prescription drug," the report notes. "To put this into perspective, AbbVie's Humira previously held the spot with $19.8 billion in sales, and Pfizer's best-selling product just prior to the pandemic achieved worldwide revenues of $5.8 billion." "Despite this record revenue in 2021," the report continues, "Pfizer began 2022 with price hikes on seven of its 10 best-selling drugs," including its pneumonia vaccine (up 6.9%), a breast cancer medication (up 6.9%), and a treatment for people with cardiovascular disease (up 6%). "These hikes of 5% or 6% can translate into thousands of dollars in higher costs for patients," P4AD notes.

Note: See also a Forbes article asking why physicians aren't challenging outrageous pricing for medical costs. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.


Investigative journalist wins British Journalism Award for "expertly researched" BMJ series
2021-12-09, The BMJ (Formerly British Medical Journal)
https://www.bmj.com/content/375/bmj.n3052

A journalist writing for The BMJ has won a British Journalism Award for his series on the financial interests of medical experts advising US and UK governments during the covid-19 pandemic. As a result of the articles written by Paul Thacker, an investigative journalist, the financial disclosures of members of the Scientific Advisory Group for Emergencies (SAGE) were published for the first time. Thacker's first story looked at two groups critical to the UK government's pandemic response–SAGE and the Vaccine Taskforce. He examined both and found that they did not disclose their members' financial conflicts. Some members were tied to companies with a monetary interest in the government's purchases. Thacker ... filed freedom of information (FoI) requests with multiple government departments and Oxford University. In a second story he wrote about the government's repeated refusal to turn over these data. However, the FoI ... revealed that Thacker's original request was apparently sent to a special government department to handle any reporter considered a "campaigner" or to have "extreme views." Eventually, the government relented and published the financial conflicts for the members of SAGE. In the final story of the series Thacker looked at the panels that the US and UK governments used to authorize vaccines and revealed that ... disclosure policies were inadequate. Some experts evaluating the vaccines had significant industry ties that were not disclosed.

Note: Read the full text of Thacker's article titled, "Covid-19: How independent were the US and British vaccine advisory committees?" and another titled "How the case of the Oxford professor exposes a transparency crisis in government." For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.


Covid Treatments Are Coming
2021-12-03, New York Times
https://www.nytimes.com/2021/12/03/briefing/covid-treatments-pfizer-merck.html

A new generation of Covid-19 treatments will soon be available, and they matter more than many people realize. They have the potential to substantially reduce hospitalization and death. In the simplest terms, they can help turn Covid into a more ordinary respiratory disease, similar to the common cold or flu, rather than one that's killing about 1,000 Americans a day and dominating daily life for millions. Two treatments are on the way – one from Pfizer and one from Merck – and they will have both medical and psychological benefits. Not only can they reduce serious Covid illness, but they can also reduce Covid fears and help society move back to normalcy. Both Pfizer's and Merck's treatments are pill regimens that people take for five days after a positive Covid test. The pills prevent the virus from replicating inside the body and are broadly similar to treatments that revolutionized H.I.V. care in the 1990s. In truth, the virus has already been largely defanged. The death rate for vaccinated adults under 50 is virtually zero. Pfizer has projected that it will produce enough doses to treat 20 million people in the first half of next year. The Biden administration has agreed to buy 10 million of the treatments, known as Paxlovid, at a cost of about $530 each. Merck projects that it will produce more than 10 million courses of its drug, called molnupiravir, by the end of this year. The federal government has agreed to buy 3.1 million of those courses for around $700 each.

Note: And thus big Pharma is set to receive another huge windfall. Why are they setting prices so how and raking in huge profits when so many are suffering financially? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.


Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial
2021-11-02, The BMJ (Formerly British Medical Journal)
https://www.bmj.com/content/375/bmj.n2635

In autumn 2020 Pfizer's chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. "As I've said before, we are operating at the speed of science," Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States. But, for researchers who were testing Pfizer's vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer's pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails. Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, she repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues.

Note: Yet every major media proudly announces "brought to you by Pfizer." For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma corruption from reliable major media sources.


Merck Will Share Formula for Its Covid Pill With Poor Countries
2021-10-27, New York Times
https://www.nytimes.com/2021/10/27/health/covid-pill-access-molnupiravir.html

Merck has granted a royalty-free license for its promising Covid-19 pill to a United Nations-backed nonprofit in a deal that would allow the drug to be manufactured and sold cheaply in the poorest nations, where vaccines for the coronavirus are in devastatingly short supply. The agreement with the Medicines Patent Pool, an organization that works to make medical treatment and technologies globally accessible, will allow companies in 105 countries, mostly in Africa and Asia, to sublicense the formulation for the antiviral pill, called molnupiravir, and begin making it. Merck reported this month that the drug halved the rate of hospitalizations and deaths in high-risk Covid patients who took it soon after infection in a large clinical trial. Affluent nations, including the United States, have rushed to negotiate deals to buy the drug, tying up large portions of the supply even before it has been approved by regulators and raising concerns that poor countries could be shut out of access to the medicine, much as they have been for vaccines. Generic drug makers in developing countries are expected to market the drug for as little as $20 per treatment (a 5-day course), compared to the $712 per course that the U.S. government has agreed to pay for its initial purchase. "The Merck license is a very good and meaningful protection for people living in countries where more than half of the world's population lives," said James Love, who leads Knowledge Ecology International, a nonprofit research organization.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop
2021-10-14, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/commentisfree/2021/oct/14/merck-drug-prices-us-he...

Merck is planning to charge Americans 40 times its cost for a Covid drug whose development was subsidized by the American government. Americans are facing not merely expensive drugs but prices that are examples of outright profiteering. In many cases, the medicines we are being gouged on are those that we the public already paid for. These facts show us that pharma-bankrolled Democrats trying to kill drug pricing measures aren't just bought and paid for in this particular skirmish – they are foot soldiers in the pharmaceutical industry's larger multi-decade campaign to seal off and rig America's alleged "free market". A new Public Citizen analysis shows that the 20 top-selling medicines generated almost twice as much pharmaceutical industry revenue in the United States as in every other country combined. For all the pharmaceutical industry's self-congratulatory rhetoric about its own innovations, the federal government uses your tax dollars to fund a lot of that innovation, research and development. A study from the National Academy of Sciences tells that story: the federal government spent $100bn to subsidize the research on every single one of the 200-plus drugs approved for sale in the United States between 2010 and 2016. We now routinely face immoral situations like last week's news that pharmaceutical giant Merck is planning to charge Americans $712 for a Covid drug that cost only $17.74 to produce and whose development was subsidized by the American government.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.


Drug Industry Hires its Former Critics as Lobbyists Against Medicare Price Negotiations
2021-10-13, The Intercept
https://theintercept.com/2021/10/13/medicare-drug-lobbying-former-democratic-...

The popular, once bipartisan idea to hold down Medicare costs is now at the center of President Joe Biden's domestic agenda. Legislation backed by the administration calls for Medicare to mirror other government agencies, such as the Department of Veterans Affairs, in being able to negotiate for cheaper medicine through the Part D program. The idea could potentially save the government nearly $500 billion over a decade. The drug pricing proposal could also translate to lower prescription costs across the board. The drug industry, according to its top lobbyist, Stephen Ubl, has made defeating the provision its top priority. Inside the Beltway, the opposition is coming from familiar faces. Many leading Democratic lawmakers and staff have been hired by the drug industry to convince their former colleagues to abandon the drug pricing proposal. Pfizer alone has assembled a lobbying team that includes Dean Aguillen, a former adviser to House Speaker Nancy Pelosi, D-Calif.; Remy Brim, a former health policy adviser to Sen. Elizabeth Warren, D-Mass.; and over half a dozen aides to senior Senate Democrats. Ann Jablon, former chief of staff to Rep. Richard Neal, D-Mass. ... currently represents several drug companies as a lobbyist, including Amgen Inc., Astellas Pharma, and Bayer. Pharmaceutical Research and Manufacturers of America, the trade group that represents the largest drug companies in the world, has also gone on a hiring spree of Democratic lobbyists.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.


Merck Sells Federally Financed COVID Pill to U.S. for 40 Times What it Costs to Make
2021-10-05, The Intercept
https://theintercept.com/2021/10/05/covid-pill-drug-pricing-merck-ridgeback/

A five-day course of molnupiravir, the new medicine being hailed as a "huge advance" in the treatment of Covid-19, costs $17.74 to produce, according to a report issued last week by drug pricing experts at the Harvard School of Public Health and King's College Hospital in London. Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price. Like the vast majority of medicines on the market, molnupiravir – which was originally investigated as a possible treatment for Venezuelan equine encephalitis – was developed using government funds. The Defense Threat Reduction Agency, a division of the Department of Defense, provided more than $10 million of funding in 2013 and 2015 to Emory University, as research done by the nonprofit Knowledge Ecology International has revealed. The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, also provided Emory with more than $19 million in additional grants. Yet only Merck and Ridgeback will reap the profits from the new antiviral, which ... could bring in as much as $7 billion by the end of this year. After the announcement of the encouraging clinical trial results on Friday, Merck's stock price climbed. Good government advocates are pointing out that because federal agencies spent at least $29 million on the drug's development, the government has the obligation to ensure that the medicine is affordable.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma profiteering from reliable major media sources.


This Is Your Brain On Drug Ads
2021-09-08, NPR
https://www.npr.org/transcripts/1035147636

British people are [asking]: What is the deal with all of these medicine ads in the U.S.? England doesn't allow commercials for prescription drugs. While there are ads for over-the-counter drugs in most of the world, the U.S. and New Zealand are the only two countries that allow drug companies to advertise prescription drugs directly to consumers. Commercials for prescription drugs do not exist in Europe or South America or Asia or Africa or Mexico or Australia, just in the U.S. and New Zealand, which is a much smaller market. It wasn't too long ago that TV in the U.S. was like the rest of the world, completely free of prescription drug ads. The '60s, the '70s, most of the '80s, there are no ads like this. By the '80s, though, ... drug companies started saying, we don't want to advertise our drugs just to doctors and pharmacists anymore. We want to market our drugs directly to consumers. The FDA was worried about how commercials would impact demand for drugs - misuse, overuse, all kinds of things. But there were compelling reasons to go directly to consumers. So in 1981, the first direct-to-consumer ad runs in print in Reader's Digest. The FDA [decided television] commercials need to say, out loud, the major risks of a drug. You just had to include the major risks of a drug, along with places where consumers could get more information about the drug, like a phone number or a website or a recommendation just to talk to your doctor. And this is what really opens the TV ad floodgates.

Note: The pharmaceutical industry provides 75% of television advertising revenue in the US. So how likely are TV stations to carry stories that reveal problems with drugs or corruption in the industry? For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.


The Sacklers, Who Made Billions From OxyContin, Win Immunity From Opioid Lawsuits
2021-09-01, NPR
https://www.npr.org/2021/09/01/1031053251/sackler-family-immunity-purdue-phar...

Members of the Sackler family who are at the center of the nation's deadly opioid crisis have won sweeping immunity from opioid lawsuits linked to their privately owned company Purdue Pharma and its OxyContin medication. Federal Judge Robert Drain approved a bankruptcy settlement on Wednesday that grants the Sacklers "global peace" from any liability for the opioid epidemic. "This is a bitter result," Drain said. "I believe that at least some of the Sackler parties have liability for those [opioid OxyContin] claims. ... I would have expected a higher settlement." The complex bankruptcy plan ... grants "releases" from liability for harm caused by OxyContin and other opioids to the Sacklers, hundreds of their associates, as well as their remaining empire of companies and trusts. In return, they have agreed to pay roughly $4.3 billion, while also forfeiting ownership of Purdue Pharma. The Sacklers, who admit no wrongdoing and who by their own reckoning earned more than $10 billion from opioid sales, will remain one of the wealthiest families in the world. Critics of this bankruptcy settlement, meanwhile, said they would challenge Drain's confirmation because of the liability releases for the Sacklers. "This order is insulting to victims of the opioid epidemic who had no voice in these proceedings," said Washington state Attorney General Bob Ferguson. The Department of Justice urged Drain to reject the settlement. Attorneys general for nine states and the District of Columbia also opposed the plan.

Note: Purdue Pharma spent $1.2 million on lobbying just before making this deal. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.


As Purdue Pharma Sought Controversial Bankruptcy Settlement, It Spent Over $1.2 Million on Lobbying
2021-08-13, The Intercept
https://theintercept.com/2021/08/13/purdue-pharma-sackler-bankruptcy-lobbying/

As Purdue Pharma seeks approval for a controversial bankruptcy settlement, it has retained the services of highly compensated lobbying firms Brownstein Hyatt Farber Schreck and Capitol Hill Consulting Group. At the Purdue Pharma bankruptcy trial that began Thursday, Judge Robert Drain is widely expected to approve a proposed settlement of the Purdue Pharma bankruptcy that would release members of the billionaire Sackler family, the company's owners, from all current and future opioid-related civil claims. In the year and a half leading up to the trial, Purdue spent at least $1.2 million on federal lobbying expenses as it worked toward the settlement, an Intercept review of lobbying records shows. If the settlement is approved, the Sacklers will be making a contribution of $4.28 billion, which will leave them with over $6 billion at minimum in total assets – money that will be effectively untouchable by opioid crisis victims, even though it is Purdue going bankrupt, not the Sacklers. "This whole bankruptcy was the Sacklers trying to buy immunity," said activist Ed Bisch, who lost his son to an OxyContin overdose in 2001 and is a claimant and active opponent of the settlement. "The only question was what would be the price." Among the lobbyists paid by Purdue Pharma – maker of the opioid painkiller OxyContin – since it filed for bankruptcy reorganization in September 2019 are politically connected Brownstein Hyatt, which received $480,000, and Capitol Hill Consulting Group, which got $300,000.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.


The Untold Story of Purdue Pharma's Cozy Relationship With the American Medical Association
2021-08-05, Mother Jones
https://www.motherjones.com/politics/2021/08/purdue-pharma-american-medical-a...

The American Medical Association's new training on pain management arrived in the midst of a burgeoning crisis. It was September 2007, and doctors were prescribing enough opioid painkillers each year for every American adult to have a bottle of the addictive pills. Overdoses were at a historic high and showed no signs of slowing down. Just four months earlier, executives at Purdue Pharma had pleaded guilty to felony charges for misleading regulators and physicians about the dangers of OxyContin. In light of this news, one might have expected the AMA ... to bring attention to the crisis in its newly updated continuing education course on how to treat pain. Instead, the 12-module training suggested that doctors were still too tentative about prescribing narcotics. "The effectiveness of opioid therapy may be undermined by misconceptions about their risks, particularly risks associated with abuse and addiction," read materials from one session. Down in the fine print, the AMA-branded course materials reveal that the training's development and distribution was made possible by an educational grant from Purdue Pharma. By now, the story of how Purdue Pharma sowed the seeds for the overdose crisis is the stuff of history books. But the years of Purdue's involvement with the AMA have been strangely absent from that narrative. Between 2002 and 2018, the AMA and the organization's philanthropic arm, the AMA Foundation, received more than $3 million from Purdue Pharma.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and health from reliable major media sources.


Vaccine monopolies make cost of vaccinating the world against COVID at least 5 times more expensive than it could be
2021-07-29, Oxfam
https://www.oxfam.org/en/press-releases/vaccine-monopolies-make-cost-vaccinat...

The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren't profiteering from their monopolies on COVID-19 vaccines, campaigners from The People's Vaccine Alliance said today. New analysis by the Alliance shows that the firms Pfizer/BioNTech and Moderna are charging governments as much as $41 billion above the estimated cost of production. Colombia, for example, has potentially overpaid by as much as $375 million for its doses of the Pfizer/BioNTech and Moderna vaccines, in comparison to the estimated cost price. Despite a rapid rise in COVID cases and deaths across the developing world, Pfizer/BioNTech and Moderna have sold over 90 percent of their vaccines so far to rich countries, charging up to 24 times the potential cost of production. Neither company have agreed to fully transfer vaccine technology and know-how with any capable producers in developing countries, a move that could increase global supply, drive down prices and save millions of lives. Analysis of production techniques for the leading mRNA type vaccines produced by Pfizer/BioNTech and Moderna ―which were only developed thanks to public funding to the tune of $8.3 billion― suggest these vaccines could be made for as little as $1.20 a dose. Yet COVAX, the scheme set up to help countries get access to COVID vaccines, has been paying, on average, nearly five times more.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and coronavirus vaccines from reliable major media sources.


Pfizer Hikes 2021 Outlook After Vaccine Boosts Sales, Profit
2021-07-28, U.S. News & World Report
https://www.usnews.com/news/best-states/new-york/articles/2021-07-28/pfizer-r...

Strong sales of its COVID-19 vaccine and other medicines helped Pfizer nearly double its second-quarter revenue and boost its profit an impressive 59%, beating Wall Street expectations and leading the drug giant to sharply hike its 2021 sales and profit forecasts. Amid the surging coronavirus pandemic, the COVID-19 vaccine became Pfizer's top seller, bringing in nearly half its revenue – $7.84 billion from direct sales and revenue split with its partner, Germany's BioNTech. Pfizer now anticipates revenue from the two-dose vaccine this year to reach $33.5 billion for the 2.1 billion doses it's contracted to provide by year end. That doesn't include a contract struck last week to provide an additional 200 million doses to the U.S. The New York company on Wednesday disclosed that ongoing testing of a booster shot, given six months after the second vaccine dose, showed it raised antibody levels against the more-transmissible Delta variant to 11 times higher in older people and five times higher in younger people, compared to levels after two doses. Pfizer has delivered more than 1 billion doses of the vaccine globally and expects to make 3 billion doses this year, with many more going to low- and middle-income countries from now through year's end. Most doses of all the COVID-19 vaccines produced in Europe and the U.S. so far have gone to wealthy countries.

Note: When public health is at stake, should private companies be making huge profits like this? Read more in this information article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and coronavirus vaccines from reliable major media sources.


J&J exploring putting talc liabilities into new business that would file for bankruptcy
2021-07-18, CNBC News
https://www.cnbc.com/2021/07/18/jj-exploring-putting-talc-liabilities-into-ba...

Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection. During settlement discussions, one of the health-care conglomerate's attorneys has told plaintiffs' lawyers that J&J could pursue the bankruptcy plan, which could result in lower payouts for cases that do not settle beforehand. Plaintiffs' lawyers would initially be unable to stop J&J from taking such a step. J&J faces legal actions from tens of thousands of plaintiffs alleging its Baby Powder and other talc products contained asbestos and caused cancer. The plaintiffs include women suffering from ovarian cancer and others battling mesothelioma. Should J&J proceed, plaintiffs who have not settled could find themselves in protracted bankruptcy proceedings with a likely much smaller company. Future payouts to plaintiffs would be dependent on how J&J decides to fund the entity housing its talc liabilities. J&J is now considering using Texas's "divisive merger" law, which allows a company to split into at least two entities. For J&J, that could create a new entity housing talc liabilities that would then file for bankruptcy to halt litigation. The maneuver is known among legal experts as a Texas two-step bankruptcy. A 2018 Reuters investigation found J&J knew for decades that asbestos, a known carcinogen, lurked in its Baby Powder and other cosmetic talc products.

Note: Can we trust this company with vaccines? For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.


Johnson & Johnson must pay $2.1 billion talc baby powder award as Supreme Court rejects appeal
2021-06-01, Chicago Tribune
https://www.chicagotribune.com/business/ct-biz-johnson-talc-supreme-court-202...

Johnson & Johnson must pay a $2.1 billion award to women who claimed its baby powder was contaminated with cancer-causing asbestos, after the U.S. Supreme Court left intact the largest verdict in the almost decadelong litigation over the iconic product. The top U.S. court without comment on Tuesday refused to consider J&J's objections to a St. Louis jury's 2018 finding that its talc-based powder helped cause ovarian cancer in 20 women. J&J prepared for the appeal's denial by announcing in February it was setting aside almost $4 billion to cover the St. Louis verdict. The company still faces more than 25,000 lawsuits blaming baby powder for causing cancers. J&J pulled the product off U.S. and Canadian shelves last year. Jurors in the St. Louis case awarded each woman $25 million in compensatory damages. The panel then added more than $4 billion in punitive damages, making the award the sixth-largest in U.S. legal history. The original verdict sparked a significant drop in J&J's shares. J&J has lost other cases at trial, with juries across the U.S. ordering it to pay hundreds of millions of dollars. Judges slashed some of those awards while others have been thrown out or are on appeal. J&J has won cases as well. Asbestos, which is often found where talc is mined, is a recognized carcinogen. The women also contended that J&J showed years of deceit about its product and disregard for the health of its customers and argued that warranted the punitive damage award.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.


Why Billionaires Like Bill Gates Can't Fix the Problems They Helped Create
2021-05-25, New York Times
https://www.nytimes.com/2021/05/25/opinion/bill-melinda-gates-foundation.html

For years, the Gates Foundation has been steered by an unusually small board of trustees, made up of Bill, his estranged wife, Melinda, and the billionaire investor Warren Buffett. The larger the foundation became, the less anyone seemed willing to ask tough questions about its secretive management structure or its penchant for giving money to lucrative pharmaceutical and credit card companies such as Mastercard, despite the fact that giving away billions to wealthy corporations set an unusual and troubling precedent in the philanthropic sector. Billionaires who make their fortunes through corporate practices that undercut workers and deepen inequality – like corporate tax avoidance, insufficient sick pay and the immoral gap in pay between executives and low-paid workers – are not the solution to problems they generate. Asking Bill Gates to fix inequality is like asking an arsonist to hose down your house after he just set it on fire. In April last year, the University of Oxford was reportedly considering offering a Covid-19 vaccine developed by its scientists on a nonexclusive basis. But then, Kaiser Health News reported, "Oxford – urged on by the Bill & Melinda Gates Foundation – reversed course. It signed an exclusive vaccine deal with AstraZeneca that gave the pharmaceutical giant sole rights and no guarantee of low prices." This dealmaking .. seemed to conflict with the Gates Foundation's stated mission to improve global access to medicines, but it's not surprising.

Note: Read more about the Gates Foundation's startling degree of media influence during the pandemic. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the coronavirus vaccine from reliable major media sources.


Covid vaccine profits mint 9 new pharma billionaires
2021-05-21, MSN News
https://www.msn.com/en-us/news/world/covid-vaccine-profits-mint-9-new-pharma-...

Covid-19 vaccines have created at least nine new billionaires after shares in companies producing the shots soared. Topping the list of new billionaires are Moderna CEO Stéphane Bancel and Ugur Sahin, the CEO of BioNTech, which has produced a vaccine with Pfizer. Both CEOs are now worth around $4 billion, according to an analysis by the People's Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now and Amnesty International. Senior executives from China's CanSino Biologics and early investors in Moderna have also become billionaires on paper as shares skyrocketed. Moderna's share price has gained more than 700% since February 2020, while BioNTech has surged 600%. CanSino Biologics' stock is up about 440% over the same period. The company's single-dose Covid-19 vaccine was approved for use in China in February. Activists said the wealth generation highlighted the stark inequality that has resulted from the pandemic. The nine new billionaires are worth a combined $19.3 billion, enough to fully vaccinate some 780 million people in low-income countries. "These billionaires are the human face of the huge profits many pharmaceutical corporations are making from the monopoly they hold on these vaccines," Anne Marriott, Oxfam's health policy manager, said. "These vaccines were funded by public money and should be first and foremost a global public good, not a private profit opportunity," she added.

Note: You would hope that with all the suffering going on in our world, big Pharma wouldn't gouge and make huge profits on their vaccines. Sadly, this is far from the truth. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus vaccine from reliable major media sources.


Documents Reveal Pharma Plot to Stop Generic COVID-19 Vaccine Waiver
2021-05-14, The Intercept
https://theintercept.com/2021/05/14/covid-vaccine-waiver-generic-phrma-lobby/

The pharmaceutical industry is distributing talking points, organizing opposition, and even collecting congressional signatures in an attempt to reverse President Joe Biden's support for worldwide access to generic Covid-19 vaccines. The behind-the-scenes moves ... come as the U.S. last week announced that it would support the World Trade Organization proposal, led by India and South Africa, to temporarily waive enforcement of intellectual property and patent rights on coronavirus vaccines. Without a radical expansion in vaccine manufacturing capacity, many developing countries will not achieve mass vaccination rates until 2023 or 2024. The waiver request, which was unexpectedly endorsed by Biden's administration on May 5, is designed to provide legal immunity for drug firms to copy the formulas of existing vaccines to supply low-cost vaccines to low-income countries. On Wednesday, Jared Michaud, a lobbyist with the Pharmaceutical Research and Manufacturers of America, a trade group that represents Pfizer, Johnson & Johnson, AstraZeneca, and other major drug firms, sent an email laying out the industry's role in coaxing lawmakers to push back against a waiver. One of the documents laid out potential national security concerns and suggested that lawmakers should argue the waiver could empower Russia and China. PhRMA ... spent over $24 million on federal lobbying last year and is one of the biggest corporate players in election spending.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus vaccine from reliable major media sources.


Big Pharma's Deadly COVID-19 Vaccine Monopoly
2021-05-12, The Intercept
https://theintercept.com/2021/05/12/intercepted-covid-vaccine-intellectual-pr...

A week ago, the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines. In response, Bio, a trade association representing biotechnology companies, issued a statement saying, "The United States has unfortunately chosen to set a dangerous precedent with these actions." Efforts to maintain intellectual property rights from life-saving drugs to vaccines have hindered the global response. The Biden administration surprised a lot of observers by coming out in favor of this ... temporary suspension of IP and patent enforcement on certain medications related to the Covid-19 pandemic. Right now, the way that wealthier countries – the U.S. and others – are confronting this crisis for the developing world is through voluntary agreements. There are really two ways to combat this crisis. There's a way to do it in a sense that maximizes profit for the healthcare companies, the pharmaceutical companies. And then there's the more collaborative, nonprofit approach. And early on, pharmaceutical companies were fighting this more collaborative approach. The pharmaceutical companies, in addition, have said they plan to increase prices once the pandemic quote-unquote ends. These companies are eagerly awaiting the opportunity to increase prices.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus vaccine from reliable major media sources.


Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.